Top of this page
Skip navigation, go straight to the content

UCB0599

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Parkinson's Disease (PD)
A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease Phase 2 PD0053
Ongoing
NCT04658186